Literature DB >> 11499546

Status of glucose transporters in the mammalian kidney and renal development.

E I Wallner1, J Wada, G Tramonti, S Lin, Y S Kanwar.   

Abstract

Glucose is the main source or energy for the mammalian cells and its entry is mediated via various transporters. About 7 facilitative (GULT-1 to -7) and 2 concentrative glucose transporters (SGLT-1 and -2) have been identified. The facilitative glucose transporters allow the glucose entry into the cell interior due to the concentration gradient and the latter via the Na+-dependent electrochemical gradient. They have similar structural motifs with 12-14 putative transmembrane domains with a predicted protein size varying from 50 to 76kDa. Some of the facilitative glucose transporters (GLUT-1, -2, -4 and -5) and both the sodium glucose co-transporters (SGLT-1 and -2) are expressed in the kidney. The transporters that are involved in the major transport of glucose in the kidney include GLUT-2 and SGLT-2. They are of high capacity and low affinity type and are expressed in the S1 segment of the proximal tubule. All the transporters expressed in the kidney are developmentally regulated. The mRNA expression of renal GLUTs is variable during the fetal and postnatal periods. On the other hand the mRNA of SGLTs increases steadily from the fetal period to maturity along with the increase in their functional activity, i.e., glucose uptake. Recent studies indicate that the SGLTs are believed to selectively regulate tubulogenesis since they are expressed in the metanephric tubules very early in the embryonic life in mammals.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11499546     DOI: 10.1081/jdi-100104714

Source DB:  PubMed          Journal:  Ren Fail        ISSN: 0886-022X            Impact factor:   2.606


  7 in total

1.  Expression of mRNA for glucose transport proteins in jejunum, liver, kidney and skeletal muscle of pigs.

Authors:  J R Aschenbach; K Steglich; G Gäbel; K U Honscha
Journal:  J Physiol Biochem       Date:  2009-09       Impact factor: 4.158

2.  Characterisation of glucose transporters in the intact coronary artery endothelium in rats: GLUT-2 upregulated by long-term hyperglycaemia.

Authors:  N Gaudreault; D R L Scriven; E D W Moore
Journal:  Diabetologia       Date:  2004-12-10       Impact factor: 10.122

3.  Transcriptional regulation of NHE3 and SGLT1 by the circadian clock protein Per1 in proximal tubule cells.

Authors:  Kristen Solocinski; Jacob Richards; Sean All; Kit-Yan Cheng; Syed J Khundmiri; Michelle L Gumz
Journal:  Am J Physiol Renal Physiol       Date:  2015-09-16

4.  Reduction in SGLT1 mRNA Expression in the Ventromedial Hypothalamus Improves the Counterregulatory Responses to Hypoglycemia in Recurrently Hypoglycemic and Diabetic Rats.

Authors:  Xiaoning Fan; Owen Chan; Yuyan Ding; Wanling Zhu; Jason Mastaitis; Robert Sherwin
Journal:  Diabetes       Date:  2015-06-30       Impact factor: 9.461

5.  Mutation of solute carrier SLC16A12 associates with a syndrome combining juvenile cataract with microcornea and renal glucosuria.

Authors:  Barbara Kloeckener-Gruissem; Kristof Vandekerckhove; Gudrun Nürnberg; John Neidhardt; Christina Zeitz; Peter Nürnberg; Isaak Schipper; Wolfgang Berger
Journal:  Am J Hum Genet       Date:  2008-02-14       Impact factor: 11.025

6.  Carcinogenicity risk assessment supports the chronic safety of dapagliflozin, an inhibitor of sodium-glucose co-transporter 2, in the treatment of type 2 diabetes mellitus.

Authors:  Timothy P Reilly; Michael J Graziano; Evan B Janovitz; Thomas E Dorr; Craig Fairchild; Francis Lee; Jian Chen; Tai Wong; Jean M Whaley; Mark Tirmenstein
Journal:  Diabetes Ther       Date:  2014-01-29       Impact factor: 2.945

7.  The diagnostic value of [18F]-FDG-PET/CT in assessment of radiation renal injury in Tibet minipigs model.

Authors:  Yu-Guang Tian; Min Yue; Bayaer Nashun; Shao-Jie Wu; Wei-Wang Gu; Yu-Jue Wang
Journal:  J Transl Med       Date:  2018-09-17       Impact factor: 5.531

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.